AstraZeneca-Oxford
Neutralising antibodies can be marker of COVID-19 vaccine efficacy
A new research shows that even a small quantity of the neutralising antibodies indicates a strong efficacy of the vaccine
In India, pseudo-nationalism trumps science in vaccine clearance
The recent regulatory clearance given to an indigenous developed vaccine candidate in India is an example of vaccine nationalism at its worst and jettisoning of all the principles of an evidence-based, scientific approach
COVID-19 vaccines: Differences, costs, and challenges
The COVID-19 pandemic saw the fastest development of a vaccine ever, with a number of research collaborations making this feat possible. But many challenges also remain
Vaccine rollout battle: First past the post may win major market share
India’s mass vaccination plans may fail if it does not hold open discussions on its plans with health professionals and the people
- Brazil approves end to 6×1 work schedule and reduction of the work week to 40 hours
- Israel kills 31 people in Lebanon on the eve of Eid al-Adha
- Israel carries out sixth consecutive Eid massacre in Gaza
- Far-right Janez Janša to return for fourth government term in Slovenia
- With peace deal nearly final, US launches fresh attacks on Iran
